eighty patients with recurrent squamous cell cancer of the head and neck were randomized to cisplatin ( 80 mg/m2 ) every 3 weeks or cisplatin plus weekly methotrexate ( 250 mg/m2 ) with leucovorin .
C0008838
cisplatin
C0280611
cisplatin